Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)
0.1425
+0.0277
(+24.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 2, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
Thursday's session: most active stocks ↗
Today 14:00 EDT
PerformanceMore NewsRead More
Top movers in Thursday's session ↗
Today 12:30 EDT
Thursday's session: gap up and gap down stocks ↗
Today 10:30 EDT
Which stocks are moving on Wednesday? ↗
June 03, 2026
Here are the top movers in Wednesday's session. ↗
June 03, 2026
Which stocks are gapping on Wednesday? ↗
June 03, 2026
Unusual volume stocks in Friday's session ↗
May 22, 2026
Friday's session: gap up and gap down stocks ↗
May 22, 2026
Most active stocks in Thursday's session ↗
May 21, 2026
Here are the top movers in Thursday's session. ↗
May 21, 2026
What's going on in today's pre-market session ↗
May 21, 2026
Which stocks are most active on Wednesday? ↗
April 15, 2026
Wondering what's happening in today's after-hours session? ↗
April 07, 2026
Frequently Asked QuestionsIs Liminatus Pharma, Inc. - Class A Common Stock publicly traded?
Yes, Liminatus Pharma, Inc. - Class A Common Stock is publicly traded.
What exchange does Liminatus Pharma, Inc. - Class A Common Stock trade on?
Liminatus Pharma, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock?
The ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock is LIMN on the Nasdaq Stock Market
What is the current price of Liminatus Pharma, Inc. - Class A Common Stock?
The current price of Liminatus Pharma, Inc. - Class A Common Stock is 0.1425
When was Liminatus Pharma, Inc. - Class A Common Stock last traded?
The last trade of Liminatus Pharma, Inc. - Class A Common Stock was at 07/02/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|